From the Health in Justice Action Lab, School of Law and College of Health Sciences, Northeastern University, Boston, MA (SK, KM, JM, LB; Division of Infectious Disease and Global Public Health, UC San Diego School of Medicine, La Jolla, CA (SK, LB); Harvard Medical School, Boston, MA (JM); Bouvé College of Health Sciences, Northeastern University, Boston, MA (KM, LB); University of Southern California, Los Angeles, CA (SK); and College of Arts, Media, and Design, Northeastern University, Boston, MA (RB).
J Addict Med. 2023;17(6):e396-e398. doi: 10.1097/ADM.0000000000001194. Epub 2023 Jun 20.
As drug-related deaths have surged, the number and scope of legal mechanisms authorizing involuntary commitment for substance use have expanded. Media coverage of involuntary commitment routinely ignores documented health and ethical concerns. Prevalence and dynamics of misinformation about involuntary commitment for substance use have not been assessed.
Media content mentioning involuntary commitment for substance use published between January 2015 and October 2020 was aggregated using MediaCloud. Articles were redundantly coded for viewpoints presented, substances mentioned, discussion of incarceration, and mentions of specific drugs. In addition, we tracked Facebook shares of coded content.
Nearly half (48%) of articles unequivocally endorsed involuntary commitment, 30% presented a mixed viewpoint, and 22% endorsed a health-based or rights-based critique. Only 7% of articles included perspectives of people with lived experience of involuntary commitment. Critical articles received nearly twice as many Facebook shares (199,909 shares) as supportive and mixed narratives combined (112,429 shares combined).
Empirical and ethical concerns about involuntary commitment for substance use are largely absent from coverage in mainstream media, as are voices of those with lived experience. Better alignment between news coverage and science is vital to inform effective policy responses to emerging public health challenges.
随着与毒品相关的死亡人数激增,授权非自愿住院治疗药物滥用的法律机制的数量和范围不断扩大。媒体对非自愿住院治疗的报道经常忽略已记录的健康和伦理问题。关于非自愿住院治疗药物滥用的错误信息的流行程度和动态尚未得到评估。
使用 MediaCloud 汇总了 2015 年 1 月至 2020 年 10 月期间发表的与非自愿住院治疗药物使用相关的媒体内容。对文章的观点、提到的物质、监禁讨论和特定药物的提及进行了重复编码。此外,我们还跟踪了编码内容的 Facebook 分享情况。
近一半(48%)的文章明确支持非自愿住院治疗,30%的文章提出了混合观点,22%的文章支持基于健康或权利的批评。只有 7%的文章包含了有非自愿住院治疗经历的人的观点。批评性文章在 Facebook 上的分享量(199909 次分享)几乎是支持性和混合叙事(共 112429 次分享)的两倍。
实证和伦理方面对药物滥用非自愿住院治疗的担忧在主流媒体的报道中基本缺失,那些有过亲身经历的人的声音也没有被听到。新闻报道与科学更好地协调对于为应对新出现的公共卫生挑战提供有效的政策应对至关重要。